The mean reductions in the treated groups were 35.4% for the supplement, 38.8% for the lotion, and 31.0% for the supplement-plus-lotion combination
doi: 10.1038/cr.2010.46 Summary Keywords Epac, exendin-4, GLP-1 receptor, methylglyoxal, mitochondrial dysfunction, oxidative stress Citation Nuamnaichati N, Mangmool S, Chattipakorn N and Parichatikanond W (2020) Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway
L Carnitine Power is a simple formula without stimulants or added fat burner ingredients
Author contributions All authors analyzed the data described in this letter and discussed their signifacances
Wegovy, approved in December 2022, was the latest to be authorised, following Saxenda (liraglutide, a drug that targets the same GLP-1 receptor as Wegovy) in July 2022 and Qsymia (a combination of phentermine and topiramate) in 2020